Callitas Health Inc.

Listing Exchange:

CSE

Status:

Delisted

Industry:

Life Sciences

Symbol:

LILY

CSE Index:

Currency:

Callitas Health Inc. (LILY)

SEDAR Information

Company Info

Address

734-1055 Dunsmuir Street

Vancouver, BC V7X 1B1

Canada

bkeane@callitas.com

Website

http://www.callitas.com

Listing date

Wednesday, January 28, 2015

Transfer Agent

TSX Trust Company

bkeane@callitas.com

Auditor

Davidson & Company LLP

Capitalization

Issued & Outstanding:

32462095

Reserved for Issuance:

Company Officers

James M. Thompson, President & Chief Executive Officer

Brian Keane, CEO

News Releases

18/06/2019

CALLITAS PROVIDES THIRD DEFAULT STATUS REPORT

30/05/2019

CALLITAS PROVIDES SECOND DEFAULT STATUS REPORT

Bulletins

08/12/2021

2021-1215 - Delist - Callitas Health Inc. (LILY)

Le 8 décembre/December 2021

The common shares ofCallitas Health Inc. will be delisted at the market close today December 8, 2021.

Callitas Health is currently suspended. See bulletin 2019-0711.

___________________

Les actions ordinaires de Callitas Health Inc. seront radiées de la cote à la clôture du marché aujourd'hui, le 8 décembre 2021.

Bulletins

08/12/2021

2021-1215 - Delist - Callitas Health Inc. (LILY)

Le 8 décembre/December 2021

The common shares ofCallitas Health Inc. will be delisted at the market close today December 8, 2021.

Callitas Health is currently suspended. See bulletin 2019-0711.

___________________

Les actions ordinaires de Callitas Health Inc. seront radiées de la cote à la clôture du marché aujourd'hui, le 8 décembre 2021.

11/07/2019

2019-0711 - Suspension - Callitas Health Inc. (LILY)

Le 11 juillet/July 2019

Callitas Health Inc. is in default of CSE requirements. Effective immediately, Callitas Health will be suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules. A cease trade order has been issued by the Ontario Securities Commission and British Columbia Securities Commission.

_______________________________

19/10/2018

2018-1027 - Reinstatement - Callitas Health Inc. (LILY)

Le 19 octobre/October 2018

Effective immediately Callitas Health Inc. will be reinstated for trading.

The Company has rectified the default situation that gave rise to the suspension.

__________________________

En vigueur immédiatement, Callitas Health Inc. sera rétabli pour le commerce.

06/09/2018

2018-0902 - Suspension - Callitas Health Inc. (LILY)

Le 6 septembre/September 2018

Callitas Health Inc. is in default of CSE requirements. Effective immediately, Callitas Health will be suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules. A cease trade order has been issued by the British Columbia and the Ontario Securities Commission.

_______________________________

19/09/2017

2017-0913 – Name and Symbol Change and Consolidation - M Pharmaceutical Inc. (MQ)

September 19, 2017

M Pharmaceutical Inc. has announced a name change to Callitas Health Inc. and a share consolidation of its issued and outstanding common shares on a one (1) post consolidation share for each ten (10) pre-consolidation common shares. No fractional shares will be issued –all fractional shares will be rounded to the nearest whole number.

As a result, the outstanding shares of the company will be reduced to approximately 32,462,095.

The shares will begin trading under the new name and symbol on September 20, 2017.

16/04/2015

2015-0407 - Consolidation - M Pharmaceutical Inc. (MQ)

Consolidation - M Pharmaceutical Inc. (MQ)

CSE Filings

File	Type	Date
Final Form 9	Notice of Issuance or Proposed Issuance of Listed Securities	23/05/2019
Monthly Progress Report May 2019	Monthly Progress Report	13/05/2019
Monthly Progress Report March 2019	Monthly Progress Report	10/04/2019
Form 7 - February 2019	Monthly Progress Report	26/03/2019
January 2019 Form 7	Monthly Progress Report	19/02/2019
Form 9	Notice of Issuance or Proposed Issuance of Listed Securities	07/02/2019
December 2018 Form 7	Monthly Progress Report	30/01/2019
November 2018 Form 7	Monthly Progress Report	30/01/2019
October 2018 Form 7	Monthly Progress Report	30/01/2019

1
2
3
4
5
6
7
8
9
…
next ›
last »

Callitas Health Inc.

You are here

Callitas Health Inc. (LILY)

SEDAR Information

Company Info

Capitalization

Company Officers

News Releases

CALLITAS PROVIDES THIRD DEFAULT STATUS REPORT

CALLITAS PROVIDES SECOND DEFAULT STATUS REPORT

Bulletins

2021-1215 - Delist - Callitas Health Inc. (LILY)

CSE Filings

Final Form 9

Monthly Progress Report May 2019

Monthly Progress Report March 2019

Form 7 - February 2019

January 2019 Form 7

Connect with us:

You are here

Callitas Health Inc.

You are here

Callitas Health Inc. (LILY)

SEDAR Information

Search form

Company Info

Capitalization

Company Officers

News Releases

News Releases

Bulletins

Bulletins

CSE Filings

CSE Filings

Connect with us: